EBOLA Update

The Ebola Virus continues to ravage the 3 Western African countries of Liberia, Guinea, and Sierra Leone even as Americans seem to be losing interest.  The World Health Organization has published the following statistics:

Guinea            2793 cases                        1797 deaths

Liberia             8263 cases                         3515 deaths

Sierra Leone   10030 cases                        2977 deaths


21,086  cases                       8,289 deaths



CBS News

There are several vaccines being developed.  Three pharmaceutical companies with vaccines in the pipeline are:

Johnson and Johnson

This vaccine is in Phase I trials where it is being given to a few volunteers to check for safety and side effects.  Two shots must be given 1-2 months apart.

Glaxo Smith Kline

This vaccine is ready for Phase II clinical trials in February.  It will be given to a larger group of people, probably in Africa. It is made from a harmless cold virus and coated with proteins from 2 strains of the Ebola virus-Zaire and Sudan.  It seems to be well tolerated and induces antibodies against Ebola.


Mercks Phase I trial was stopped for a short period when volunteers experienced joint pain.  It has now resumed using a lower dose and seems to be well tolerated.